Summary
Applied Genetic Technologies Corp (AGTC) is a pharmaceutical company that provides development of eye disease cures. The company develops treatments for patients that have diseases caused by broken genes. Its products include x-linked retinoschisis, achromatopsia, x-linked retinitis pigmentosa, alpha-1 antitrypsin deficiency and macular degeneration. AGTC’s achromatopsia provides treatment inherited conditions that is associated with visual acuity loss, extreme light sensitivity resulting in daytime blindness, and total loss of color discrimination. The company’s x-linked retinoschisis provides treatment in retinal degeneration affecting young males, presenting with poor vision by school age. It also provides ophthalmology development programs and proof-of-concept data in multiple indications. The company operates through its offices in Alachua and Cambridge, the US. AGTC is headquartered in Alachua, Florida, the US.
Applied Genetic Technologies Corp (AGTC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Applied Genetic Technologies Corp, Medical Devices Deals, 2011 to YTD 2017 9
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Applied Genetic Technologies Raises US$37.5 Million In Series B Financing 11
Applied Genetic Technologies Raises US$0.8 Million In Venture Financing 12
Partnerships 13
Applied Genetic Tech Enters into R&D Agreement with Bionic Sight 13
Applied Genetic Technologies Enters into Co-Development Agreement with BCM Families Foundation 13
Applied Genetic Technologies Enters into R&D Agreement with Synpromics 14
Licensing Agreements 15
Biogen Enters into Licensing Agreement with Applied Genetic Technologies 15
Applied Genetic Technologies Enters into Licensing Agreement with 4D Molecular Therapeutics 16
Equity Offering 17
Applied Genetic Completes Underwriters Exercise of Over-Allotment Option for Public Offering of Shares for USD34.5 Million 17
Applied Genetic Technologies Completes IPO For US$57.5 Million 18
Applied Genetic Technologies Corp - Key Competitors 21
Key Employees 22
Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24
List of Tables
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Key Facts, 2016 1
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Applied Genetic Technologies Corp, Deals By Therapy Area, 2011 to YTD 2017 8
Applied Genetic Technologies Corp, Medical Devices Deals, 2011 to YTD 2017 9
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Applied Genetic Technologies Raises US$37.5 Million In Series B Financing 11
Applied Genetic Technologies Raises US$0.8 Million In Venture Financing 12
Applied Genetic Tech Enters into R&D Agreement with Bionic Sight 13
Applied Genetic Technologies Enters into Co-Development Agreement with BCM Families Foundation 13
Applied Genetic Technologies Enters into R&D Agreement with Synpromics 14
Biogen Enters into Licensing Agreement with Applied Genetic Technologies 15
Applied Genetic Technologies Enters into Licensing Agreement with 4D Molecular Therapeutics 16
Applied Genetic Completes Underwriters Exercise of Over-Allotment Option for Public Offering of Shares for USD34.5 Million 17
Applied Genetic Technologies Completes IPO For US$57.5 Million 18
Applied Genetic Technologies Corp, Key Competitors 21
Applied Genetic Technologies Corp, Key Employees 22
Applied Genetic Technologies Corp, Other Locations 23
List of Figures
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Applied Genetic Technologies Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Applied Genetic Technologies Corp, Medical Devices Deals, 2011 to YTD 2017 9